Sotera Health (NASDAQ:SHC) Director Pincus & Co. Warburg Sells 12,000,000 Shares

Key Points

• A director at Sotera Health sold 12 million shares for a total of $181.32 million, reducing their stake by 16.26%.
• The company reported $0.20 earnings per share for the last quarter, exceeding analysts' expectations and reflecting a 6.4% increase in revenue year-over-year.
• Sotera Health currently holds a market cap of $4.49 billion and has a price-to-earnings ratio of 197.65.

Sotera Health Company (NASDAQ:SHC - Get Free Report) Director Pincus & Co. Warburg sold 12,000,000 shares of Sotera Health stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $15.11, for a total value of $181,320,000.00. Following the transaction, the director owned 61,822,952 shares of the company's stock, valued at $934,144,804.72. This trade represents a 16.26% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Sotera Health Stock Down 0.4%

SHC stock traded down $0.07 during mid-day trading on Friday, reaching $16.05. 2,486,837 shares of the company traded hands, compared to its average volume of 2,383,320. The stock has a market cap of $4.56 billion, a price-to-earnings ratio of 200.65 and a beta of 1.84. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 4.49. Sotera Health Company has a fifty-two week low of $9.53 and a fifty-two week high of $16.99. The firm's 50 day moving average price is $13.78 and its 200 day moving average price is $12.42.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings results on Friday, August 8th. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.17 by $0.03. The business had revenue of $294.34 million during the quarter, compared to the consensus estimate of $275.81 million. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The company's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.19 EPS. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. As a group, equities research analysts predict that Sotera Health Company will post 0.61 EPS for the current fiscal year.

Hedge Funds Weigh In On Sotera Health

Hedge funds and other institutional investors have recently modified their holdings of the business. TPG GP A LLC purchased a new position in Sotera Health in the first quarter valued at approximately $79,126,000. Sculptor Capital LP purchased a new position in Sotera Health in the fourth quarter valued at approximately $68,400,000. Two Seas Capital LP lifted its stake in Sotera Health by 624.0% in the fourth quarter. Two Seas Capital LP now owns 2,896,136 shares of the company's stock valued at $39,619,000 after purchasing an additional 2,496,136 shares during the last quarter. Ananym Capital Management LP purchased a new position in Sotera Health in the fourth quarter valued at approximately $13,680,000. Finally, Norges Bank purchased a new position in Sotera Health in the second quarter valued at approximately $9,607,000. Hedge funds and other institutional investors own 91.03% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Barclays reiterated an "overweight" rating on shares of Sotera Health in a research note on Friday, August 8th. Wall Street Zen upgraded Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $16.00.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.